Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Holding(s) in Company

7 Mar 2014 13:10

RNS Number : 8161B
Pressure Technologies PLC
07 March 2014
 



 

TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

 

Pressure Technologies plc

 

2. Reason for the notification (please state Yes/No):

 

An acquisition or disposal of voting rights: (Yes)

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: (No)

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments: (No)

 

An event changing the breakdown of voting rights: (No)

 

Other (please specify): (No)

 

3. Full name of person(s) subject to the notification obligation (iii):

 

Miton Group plc

 

4. Full name of shareholder(s) (if different from 3.) (iv):

 

See section 9 below

 

5. Date of the transaction and date on which the threshold is crossed or reached (v):

 

04/03/14

 

6. Date on which issuer notified:

 

05/03/14

 

7. Threshold(s) that is/are crossed or reached:

 

Was 4.38%, Now 5.34%

 

8. Notified details:

 

 

A: Voting rights attached to shares (viii), (ix)

 

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Number of shares

Number of voting Rights

GB00B1XFKR57

497,990

497,990

 

Resulting situation after the triggering transaction

Class/type of shares if possible using the ISIN CODE

Number of shares

Number of voting rights (ix)

% of voting rights (x)

Direct

Direct (xi)

Indirect (xii)

Direct

Indirect

GB00B1XFKR57

606,685

n/a

606,685

n/a

5.34%

 

B: Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date (xiii)

Exercise/Conversion Period (xiv)

Number of voting rights that may be acquired if the instrument is exercised/ converted

% of voting rights

 

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments(xv), (xvi)

 

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date (xvii)

Exercise/Conversion period (xviii)

Number of voting rights instrument refers to

% of voting rights (xix), (xx)

 

 

 

 

Nominal

Delta

 

 

 

 

Total (A+B+C)

 

Number of voting rights

% of voting rights

606,685

5.34%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xxi):

 

CF Miton UK Multicap Income Fund - Bank of New York Nominees Ltd a/c 397449 497,990

 

CF Miton UK Smaller Companies Fund - Bank of New York Nominees Ltd a/c 397904 108,695

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 

N/A

 

11. Number of voting rights proxy holder will cease to hold:

 

N/A

 

12. Date on which proxy holder will cease to hold voting rights:

 

N/A

 

13. Additional information:

 

Miton Capital Partners Limited

Miton Asset Management Ltd

are both subsidiaries of Miton Group plc

 

14. Contact name:

 

Marion Riley

 

15. Contact telephone number:

 

0151 906 2463

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBRORSBAORAR
Date   Source Headline
20th Mar 202512:02 pmRNSResults of 2025 Annual General Meeting
20th Mar 20257:00 amRNS2025 Annual General Meeting & Trading Update
19th Mar 20257:00 amRNSHydrogen Storage Contract Placement
5th Mar 20252:30 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSNotice of Annual General Meeting
5th Feb 20257:20 amRNS2024 Full-Year Results
5th Feb 20257:00 amRNSProposed Change of Name and TIDM
28th Jan 20257:00 amRNSNotice of Results and Investor Presentation
28th Jan 20257:00 amRNSDefence Contract Placement
1st Nov 202412:00 pmRNSBoard Change
1st Nov 202410:38 amRNSPDMR / PCA Shareholding
24th Oct 20247:00 amRNSMajor Contract Placement
18th Oct 20242:03 pmRNSPDMR/PCA Shareholding
9th Oct 20247:00 amRNSCompletion of Sale of PMC Division
27th Sep 20243:40 pmRNSSale of PMC and Board Changes
20th Sep 20247:00 amRNSUpdate on Sale of PMC Division & Trading
25th Jun 20247:00 amRNS2024 Interim Results
21st Mar 202412:10 pmRNSResults of 2024 Annual General Meeting
14th Mar 20247:00 amRNSContract Placements and Update on Sale of PMC
14th Feb 20247:00 amRNSNotice of 2024 Annual General Meeting
30th Jan 20247:00 amRNS2023 Full-Year Results
16th Nov 20237:00 amRNSDebt Refinancing and Grant of Warrants
24th Oct 20237:00 amRNSDebt Refinancing - Agreement in Principle
9th Oct 20239:28 amRNSHolding(s) in Company
5th Oct 20233:56 pmRNSHolding(s) in Company
5th Oct 20233:52 pmRNSHolding(s) in Company
5th Oct 20232:38 pmRNSHolding(s) in Company
4th Oct 20233:10 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSPost-Close Update
11th Aug 20232:24 pmRNSHolding(s) in Company
27th Jun 20237:00 amRNS2023 Interim Results
13th Jun 202311:40 amRNSResult of General Meeting
26th May 202312:02 pmRNSHolding(s) in Company
23rd May 20237:30 amRNSRestoration - Pressure Technologies plc
23rd May 20237:05 amRNSConfirmation of Board Appointments
23rd May 20237:00 amRNS2022 Full-Year Results
27th Apr 202310:30 amRNSFurther Update on FY22 Annual Report & Accounts
3rd Apr 20237:30 amRNSSuspension - Pressure Technologies plc
31st Mar 20231:56 pmRNSResult of AGM
27th Mar 20237:05 amRNSMajor Order Placement
27th Mar 20237:00 amRNSUpdate on Annual Report and Accounts
21st Mar 20237:05 amRNSBoard Appointments
21st Mar 20237:00 amRNSUpdate on FY22 Audit, AGM & Current Trading
7th Mar 20237:00 amRNSNotice of AGM
6th Feb 20237:00 amRNSContract
17th Jan 20237:00 amRNSAppointment of Chief Financial Officer
21st Dec 202211:57 amRNSHolding(s) in Company
8th Dec 20227:58 amRNSHolding(s) in Company
7th Dec 20221:44 pmRNSHolding(s) in Company
2nd Dec 20221:20 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.